Jump to content
  • 0

How did Gerresheimer perform in the second quarter and how are traders reacting to the earnings announcement?

Grace A


1 answer to this question

Recommended Posts

  • 0

Shares of Gerresheimer AG (ETR:GXI) are soaring by more than 8% on Thursday after the German pharmaceutical packaging firm reported more than a 140% surge in net income for the second quarter and reiterated its full-year revenue guidance.

Gerresheimer, the German-based manufacturer of primary packaging products for medication reported a net profit of €47.1m for the three months to 31st May compared with €19.3m in the previous year. Likewise, the quarterly earnings before interest, taxes, depreciation and amortisation (EBITDA) surged by 38% to €99.4m while revenues rose 7.2% to €356.5m respectively.

Gerresheimer maintained its revenue outlook of €1.40-1.45bn for full-year 2019 while it anticipated adjusted EBITDA to come in at around €295m, +/- €5m, excluding the €118.5m already accounted for from the acquisition of Sensile Medical.

At 12.30pm GMT on Thursday, shares of Gerresheimer were trading at €70.65, soaring 8.61% for the session. The company’s stock has had a rollicking year with prices jumping more than 23% YTD compared to the 17% gains on the DAX 30.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. To reply to this question, sign in or create a new account.

Reply to this question

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Create New...